Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Khatib, R; McKee, M; Shannon H.; Chow C.; Rangarajan, S; Teo, K; Wei, L; Mony, P; Mohan, V; Gupta R.; Kumar, R; Vijayakumar, K; Lear S.A.; Díaz R; Avezum, A; et. al.

Más información

Título según WOS: Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
Título según SCOPUS: Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data
Título de la Revista: LANCET
Volumen: 387
Número: 10013
Editorial: Elsevier Science Inc.
Fecha de publicación: 2016
Página de inicio: 61
Página final: 69
Idioma: English
DOI:

10.1016/S0140-6736(15)00469

Notas: ISI, SCOPUS